E Martinez, B Taminiau, C Rodriguez, G Daube - Pathogens, 2022 - mdpi.com
Clostridioides difficile is an anaerobic Gram-positive and spore-forming bacterium. The majority of C. difficile strains produce two toxins, A and B, associated with the development …
H Tian, J Cui, C Ye, J Zhao, B Yang, Y Xu, S Ji… - Gut …, 2023 - Taylor & Francis
Approximately 10% of individuals diagnosed with Clostridium difficile infection (CDI) show the resistance to fecal microbiota transplantation (FMT), with the underlying mechanisms …
Abstract The Asia Pacific region, home to two-thirds of the world's population and ten of the least developed countries, is considered a regional hot-spot for the emergence and spread …
JJ Dawkins, JR Allegretti, TE Gibson, E McClure… - Microbiome, 2022 - Springer
Background Clostridioides difficile infection (CDI) is the most common hospital acquired infection in the USA, with recurrence rates> 15%. Although primary CDI has been …
V Guéneau, J Plateau-Gonthier, L Arnaud, JC Piard… - Biofilm, 2022 - Elsevier
The increase in human consumption of animal proteins implies changes in the management of meat production. This is followed by increasingly restrictive regulations on antimicrobial …
J Hu, Y Li, S Pakpour, S Wang, Z Pan, J Liu… - Frontiers in Cellular …, 2019 - frontiersin.org
Oral supplemented nutraceuticals derived from food sources are surmised to improve the human health through interaction with the gastrointestinal bacteria. However, the lack of …
Many studies link the composition of the human gut microbiome to aberrant health states. However, our understanding of what constitutes a 'healthy'gut ecosystem, and how to …
Age-related macular degeneration (AMD) is a complex disease with increasing numbers of individuals being afflicted and treatment modalities limited. There are strong interactions …
S Vázquez-Cuesta, N Lozano García… - Frontiers in Cellular …, 2023 - frontiersin.org
Introduction Clostridioides difficile infection (CDI) is the main cause of nosocomial diarrhoea in developed countries. Recurrent CDI (R-CDI), which affects 20%-30% of patients and …